- Home
- FRPH vs XOMA Comparison
FRPH vs XOMA Comparison
Compare FRPH & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- XOMA
- Stock Information
- Founded
- FRPH 1986
- XOMA 1981
- Country
- FRPH United States
- XOMA United States
- Employees
- FRPH N/A
- XOMA N/A
- Industry
- FRPH Real Estate
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- FRPH Finance
- XOMA Health Care
- Exchange
- FRPH Nasdaq
- XOMA Nasdaq
- Market Cap
- FRPH 459.4M
- XOMA 457.6M
- IPO Year
- FRPH N/A
- XOMA N/A
- Fundamental
- Price
- FRPH $25.04
- XOMA $34.72
- Analyst Decision
- FRPH
- XOMA Strong Buy
- Analyst Count
- FRPH 0
- XOMA 2
- Target Price
- FRPH N/A
- XOMA $69.50
- AVG Volume (30 Days)
- FRPH 53.3K
- XOMA 49.7K
- Earning Date
- FRPH 11-10-2025
- XOMA 11-05-2025
- Dividend Yield
- FRPH N/A
- XOMA N/A
- EPS Growth
- FRPH N/A
- XOMA N/A
- EPS
- FRPH 0.28
- XOMA N/A
- Revenue
- FRPH $32,293,999.00
- XOMA $44,952,000.00
- Revenue This Year
- FRPH N/A
- XOMA $88.91
- Revenue Next Year
- FRPH N/A
- XOMA $13.80
- P/E Ratio
- FRPH $89.24
- XOMA N/A
- Revenue Growth
- FRPH 3.18
- XOMA 194.98
- 52 Week Low
- FRPH $23.52
- XOMA $18.35
- 52 Week High
- FRPH $33.00
- XOMA $39.92
- Technical
- Relative Strength Index (RSI)
- FRPH 52.08
- XOMA 45.80
- Support Level
- FRPH $24.57
- XOMA $33.04
- Resistance Level
- FRPH $25.55
- XOMA $35.60
- Average True Range (ATR)
- FRPH 0.52
- XOMA 1.91
- MACD
- FRPH 0.11
- XOMA -0.51
- Stochastic Oscillator
- FRPH 68.85
- XOMA 28.07
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.